BACKGROUND: Evidence for linkage of albuminuria to GABRB3 marker region on chromosome 15q12 was previously reported in Mexican Americans. The objective of this study is to scan a positional candidate gene, Transient Receptor Potential cation channel, subfamily M 1 (TRPM1), for genetic variants that may contribute to the variation in albumin-to-creatinine ratio (ACR). METHODS: To identify the sequence variants, the exons and 2 kb putative promoter region of TRPM1 were PCR amplified and sequenced in 32 selected individuals. Identified variants were genotyped in the entire data set (N=670; 39 large families) by TaqMan assays. Association analyses between the sequence variants and ACR, type 2 diabetes (T2DM) and related phenotypes were carried out using a measured genotype approach as implemented in the program SOLAR. RESULTS: Sequencing analysis identified 18 single nucleotide polymorphisms (SNPs) including 8 SNPs in the coding regions, 7 SNPs in the promoter region and 3 SNPs in introns. Of the 8 SNPs identified in the coding regions, 3 were non synonymous [Met(1)Thr, Ser(32)Asn, Val(1395)Ile] and one SNP caused stop codon (Glu1375/*). Of the SNPs examined, none of them exhibited statistically significant association with ACR after accounting for the effect of age, sex, diabetes, duration of diabetes, systolic blood pressure and anti-hypertensive medications. However, a SNP (rs11070811) located in the putative promoter region showed a modest association with triglycerides levels (P=0.039). CONCLUSION: The present investigation found no evidence for an association between sequence variation at the TRPM1 gene and ACR in Mexican Americans, although it appears to have modest influence on T2DM risk factors.
BACKGROUND: Evidence for linkage of albuminuria to GABRB3 marker region on chromosome 15q12 was previously reported in Mexican Americans. The objective of this study is to scan a positional candidate gene, Transient Receptor Potential cation channel, subfamily M 1 (TRPM1), for genetic variants that may contribute to the variation in albumin-to-creatinine ratio (ACR). METHODS: To identify the sequence variants, the exons and 2 kb putative promoter region of TRPM1 were PCR amplified and sequenced in 32 selected individuals. Identified variants were genotyped in the entire data set (N=670; 39 large families) by TaqMan assays. Association analyses between the sequence variants and ACR, type 2 diabetes (T2DM) and related phenotypes were carried out using a measured genotype approach as implemented in the program SOLAR. RESULTS: Sequencing analysis identified 18 single nucleotide polymorphisms (SNPs) including 8 SNPs in the coding regions, 7 SNPs in the promoter region and 3 SNPs in introns. Of the 8 SNPs identified in the coding regions, 3 were non synonymous [Met(1)Thr, Ser(32)Asn, Val(1395)Ile] and one SNP caused stop codon (Glu1375/*). Of the SNPs examined, none of them exhibited statistically significant association with ACR after accounting for the effect of age, sex, diabetes, duration of diabetes, systolic blood pressure and anti-hypertensive medications. However, a SNP (rs11070811) located in the putative promoter region showed a modest association with triglycerides levels (P=0.039). CONCLUSION: The present investigation found no evidence for an association between sequence variation at the TRPM1 gene and ACR in Mexican Americans, although it appears to have modest influence on T2DM risk factors.
Authors: Vladimir Chubanov; Siegfried Waldegger; Michael Mederos y Schnitzler; Helga Vitzthum; Martin C Sassen; Hannsjörg W Seyberth; Martin Konrad; Thomas Gudermann Journal: Proc Natl Acad Sci U S A Date: 2004-02-19 Impact factor: 11.205
Authors: Joost G J Hoenderop; Johannes P T M van Leeuwen; Bram C J van der Eerden; Ferry F J Kersten; Annemiete W C M van der Kemp; Anne-Marie Mérillat; Jan H Waarsing; Bernard C Rossier; Volker Vallon; Edith Hummler; René J M Bindels Journal: J Clin Invest Date: 2003-12 Impact factor: 14.808
Authors: Surya M Nauli; Francis J Alenghat; Ying Luo; Eric Williams; Peter Vassilev; Xiaogang Li; Andrew E H Elia; Weining Lu; Edward M Brown; Stephen J Quinn; Donald E Ingber; Jing Zhou Journal: Nat Genet Date: 2003-01-06 Impact factor: 38.330
Authors: Arlo J Miller; Jinyan Du; Sheldon Rowan; Christine L Hershey; Hans R Widlund; David E Fisher Journal: Cancer Res Date: 2004-01-15 Impact factor: 12.701
Authors: Dawn M Waterworth; Sally L Ricketts; Kijoung Song; Li Chen; Jing Hua Zhao; Samuli Ripatti; Yurii S Aulchenko; Weihua Zhang; Xin Yuan; Noha Lim; Jian'an Luan; Sofie Ashford; Eleanor Wheeler; Elizabeth H Young; David Hadley; John R Thompson; Peter S Braund; Toby Johnson; Maksim Struchalin; Ida Surakka; Robert Luben; Kay-Tee Khaw; Sheila A Rodwell; Ruth J F Loos; S Matthijs Boekholdt; Michael Inouye; Panagiotis Deloukas; Paul Elliott; David Schlessinger; Serena Sanna; Angelo Scuteri; Anne Jackson; Karen L Mohlke; Jaako Tuomilehto; Robert Roberts; Alexandre Stewart; Y Antero Kesäniemi; Robert W Mahley; Scott M Grundy; Wendy McArdle; Lon Cardon; Gérard Waeber; Peter Vollenweider; John C Chambers; Michael Boehnke; Gonçalo R Abecasis; Veikko Salomaa; Marjo-Riitta Järvelin; Aimo Ruokonen; Inês Barroso; Stephen E Epstein; Hakon H Hakonarson; Daniel J Rader; Muredach P Reilly; Jacqueline C M Witteman; Alistair S Hall; Nilesh J Samani; David P Strachan; Philip Barter; Cornelia M van Duijn; Jaspal S Kooner; Leena Peltonen; Nicholas J Wareham; Ruth McPherson; Vincent Mooser; Manjinder S Sandhu Journal: Arterioscler Thromb Vasc Biol Date: 2010-09-23 Impact factor: 8.311
Authors: Sofia Galvão Feronato; Maria Luiza Matos Silva; Rafael Izbicki; Ticiana D J Farias; Patrícia Shigunov; Bruno Dallagiovanna; Fabio Passetti; Hellen Geremias Dos Santos Journal: J Pers Med Date: 2022-08-19